Journal
PPAR RESEARCH
Volume 2012, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2012/738785
Keywords
-
Categories
Ask authors/readers for more resources
Hepatic ischemia-reperfusion (IR) injury is a serious clinical problem. Minimizing the adverse effect of ischemia-reperfusion injury after liver surgery or trauma is an urgent need. It has been proved that besides the effect of regulating the lipid and lipoprotein metabolism, PPAR alpha also undertakes the task of organ protection. In this paper, related literature has been summarized and we come to the conclusion that administration of PPAR alpha agonists can strengthen the antioxidant and anti-inflammation defense system by the upregulation of the expression of antioxidant enzymes and inhibition of NF-kappa B activity. This may provide a potential clinical treatment for hepatic ischemia-reperfusion injury.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available